rs121912776
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP2PP3PP5
The NM_000719.7(CACNA1C):c.116C>T(p.Ala39Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 34)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CACNA1C
NM_000719.7 missense
NM_000719.7 missense
Scores
11
3
3
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1C. . Gene score misZ 6.4654 (greater than the threshold 3.09). Trascript score misZ 7.2674 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.836
PP5
Variant 12-2115290-C-T is Pathogenic according to our data. Variant chr12-2115290-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 17635.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.206C>T | p.Ala69Val | missense_variant | 2/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.116C>T | p.Ala39Val | missense_variant | 2/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.206C>T | p.Ala69Val | missense_variant | 2/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.116C>T | p.Ala39Val | missense_variant | 2/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.116C>T | p.Ala39Val | missense_variant | 2/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.116C>T | p.Ala39Val | missense_variant | 2/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.206C>T | p.Ala69Val | missense_variant | 2/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.206C>T | p.Ala69Val | missense_variant | 2/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.206C>T | p.Ala69Val | missense_variant | 2/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.206C>T | p.Ala69Val | missense_variant | 2/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.116C>T | p.Ala39Val | missense_variant | 2/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.116C>T | p.Ala39Val | missense_variant | 2/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.116C>T | p.Ala39Val | missense_variant | 2/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.116C>T | p.Ala39Val | missense_variant | 2/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.116C>T | p.Ala39Val | missense_variant | 2/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.116C>T | p.Ala39Val | missense_variant | 2/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.116C>T | p.Ala39Val | missense_variant | 2/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.116C>T | p.Ala39Val | missense_variant | 2/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000682152.1 | c.65C>T | p.Ala22Val | missense_variant | 1/6 | ENSP00000506759.1 | ||||
CACNA1C | ENST00000480911.6 | n.116C>T | non_coding_transcript_exon_variant | 2/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 genomes
Cov.:
34
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.94e-7 AC: 1AN: 1440238Hom.: 0 Cov.: 32 AF XY: 0.00000140 AC XY: 1AN XY: 714900
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1440238
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
714900
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 34
GnomAD4 genome
Cov.:
34
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1Other:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Brugada syndrome 3 Pathogenic:1Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 30, 2007 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Brugada syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Brugada syndrome in the following publications (PMID:17224476;PMID:20817017;PMID:22385640). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
.;.;N;.;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
1.0, 0.14, 1.0, 0.98
.;.;D;.;B;D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;.;.;.;.
Vest4
0.64, 0.65, 0.50, 0.65, 0.65, 0.56, 0.66, 0.61, 0.70, 0.58, 0.64, 0.61, 0.58, 0.65, 0.50, 0.61, 0.66, 0.63, 0.62, 0.64, 0.83
MutPred
0.55
.;Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);Gain of catalytic residue at E41 (P = 0.0095);
MVP
MPC
2.1
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at